Primary malignant melanoma of uterine cervix treated with pembrolizumab as adjuvant immunotherapy

This is the case report of primary malignant melanoma (MM) of uterine cervix treated by immune checkpoint inhibitor: the Pembrolizumab. Despite the merge of the novel drugs that has been strikingly improving prognosis of MM, we still struggle treatment of MM of uterine cervix that has aggressive cha...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int Cancer Conf J
Asıl Yazarlar: Suzuki, Reiko, Endo, Hiraku, Sasaki, Takamichi, Nakamura, Takayoshi, Yamanaka, Hiroyuki, Hosonuma, Shinji, Kuji, Shiho, Deura, Imari, Ohara, Tatsuru, Kondo, Haruhiro, Chosokabe, Motohiro, Koike, Junki, Kadono, Hiroshi, Hasegawa, Junichi, Suzuki, Nao
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Singapore 2021
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8206436/
https://ncbi.nlm.nih.gov/pubmed/34221842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-021-00477-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller